BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27920806)

  • 1. Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern.
    Beltrami G; Ristori G; Scoccianti G; Tamburini A; Capanna R
    Clin Cases Miner Bone Metab; 2016; 13(2):110-118. PubMed ID: 27920806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Multiple Exostoses: Current Insights.
    D'Arienzo A; Andreani L; Sacchetti F; Colangeli S; Capanna R
    Orthop Res Rev; 2019; 11():199-211. PubMed ID: 31853203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic roles of heparan sulfate deficiency in hereditary multiple exostoses.
    Pacifici M
    Matrix Biol; 2018 Oct; 71-72():28-39. PubMed ID: 29277722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous malformation may be a feature of EXT1-related hereditary multiple exostoses: A report of two unrelated probands.
    Albokhari D; Bailey CR; Hwang F; Weiss CR; Forsberg J; Sobreira N
    Am J Med Genet A; 2023 Jun; 191(6):1570-1575. PubMed ID: 36869625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple hereditary exostoses (MHE): elucidating the pathogenesis of a rare skeletal disorder through interdisciplinary research.
    Jones KB; Pacifici M; Hilton MJ
    Connect Tissue Res; 2014 Apr; 55(2):80-8. PubMed ID: 24409815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palovarotene Inhibits Osteochondroma Formation in a Mouse Model of Multiple Hereditary Exostoses.
    Inubushi T; Lemire I; Irie F; Yamaguchi Y
    J Bone Miner Res; 2018 Apr; 33(4):658-666. PubMed ID: 29120519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the pathogenesis and possible treatments for multiple hereditary exostoses from the 2016 international MHE conference.
    Phan AQ; Pacifici M; Esko JD
    Connect Tissue Res; 2018 Jan; 59(1):85-98. PubMed ID: 29099240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary multiple exostoses and enchondromatosis.
    Pannier S; Legeai-Mallet L
    Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):45-54. PubMed ID: 18328980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary Multiple Exostoses: New Insights into Pathogenesis, Clinical Complications, and Potential Treatments.
    Pacifici M
    Curr Osteoporos Rep; 2017 Jun; 15(3):142-152. PubMed ID: 28466453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary Multiple Exostoses-A Review of the Molecular Background, Diagnostics, and Potential Therapeutic Strategies.
    Bukowska-Olech E; Trzebiatowska W; Czech W; Drzymała O; Frąk P; Klarowski F; Kłusek P; Szwajkowska A; Jamsheer A
    Front Genet; 2021; 12():759129. PubMed ID: 34956317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type 2 diabetes associated rs7903146 T allele within TCF7L2 is significantly under-represented in Hereditary Multiple Exostoses: insights into pathogenesis.
    Sgariglia F; Pedrini E; Bradfield JP; Bhatti TR; D'Adamo P; Dormans JP; Gunawardena AT; Hakonarson H; Hecht JT; Sangiorgi L; Pacifici M; Enomoto-Iwamoto M; Grant SF
    Bone; 2015 Mar; 72():123-7. PubMed ID: 25498973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etiological point mutations in the hereditary multiple exostoses gene EXT1: a functional analysis of heparan sulfate polymerase activity.
    Cheung PK; McCormick C; Crawford BE; Esko JD; Tufaro F; Duncan G
    Am J Hum Genet; 2001 Jul; 69(1):55-66. PubMed ID: 11391482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mutation in ext2 caused hereditary multiple exostoses through reducing the synthesis of heparan sulfate.
    Xian C; Zhu M; Nong T; Li Y; Xie X; Li X; Li J; Li J; Wu J; Shi W; Wei P; Xu H; Tang YP
    Genet Mol Biol; 2021; 44(2):e20200334. PubMed ID: 34042151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
    Chen WC; Chi CH; Chuang CC; Jou IM
    J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the general population frequency of rare coding variants in the EXT1 and EXT2 genes previously implicated in hereditary multiple exostoses.
    Cousminer DL; Arkader A; Voight BF; Pacifici M; Grant SFA
    Bone; 2016 Nov; 92():196-200. PubMed ID: 27616605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary multiple exostoses: are there new plausible treatment strategies?
    Pacifici M
    Expert Opin Orphan Drugs; 2018; 6(6):385-391. PubMed ID: 31448184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutations of EXT1 and EXT2 genes among families and sporadic cases with multiple exostoses.
    Pei Y; Wang Y; Huang W; Hu B; Huang D; Zhou Y; Su P
    Genet Test Mol Biomarkers; 2010 Dec; 14(6):865-72. PubMed ID: 21039224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation-induced loss of heparan sulfate in human exostosis derived chondrocytes.
    Hecht JT; Hayes E; Haynes R; Cole WG; Long RJ; Farach-Carson MC; Carson DD
    Differentiation; 2005 Jun; 73(5):212-21. PubMed ID: 16026543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel exostosin-2 mutation identified in a Chinese family with hereditary multiple osteochondroma.
    Ruan W; Cao L; Chen Z; Kong M; Bi Q
    Oncol Lett; 2018 Apr; 15(4):4383-4389. PubMed ID: 29541207
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.